Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 15, Issue 11
|
pp. 4963–4985
FDX1 serves as a prognostic biomarker and promotes glioma progression by regulating the immune response
Back to article
Figure 4
(4 of 9)
−
100%
+
Figure 4.
Function and pathway enrichment analysis.
(
A
) GO enrichment analysis. (
B
) GSVA analysis in high- and low-FDX1 expression groups.
Figure 4 — FDX1 serves as a prognostic biomarker and promotes glioma progression by regulating the immune response | Aging
